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1. Introduction 
Emergency department (ED) is one place in the hospital where variety of patients encounter 
happen on a routine basis, of varied nature and severity, many of which are associated with 
varying degree of pain and anxiety. Hence, sedation and analgesia is an important component 
of acute care provided in the ED. Use of appropriate analgesia and sedation is about striking 
balance between patient comfort and needs and avoidance of hindering clinical findings to 
deliver a safe, appropriate and effective care but in comfortable and humane in nature.  
2. Definitions 
Conscious sedation, being used loosely in the ED for all form of sedations, was first 
described in 1985 as “light level of sedation where patient retains the ability to 
independently maintain an airway and respond appropriately to verbal commands” (1). In 
reality, the level of sedation used in ED is deeper than what was described as conscious 
sedation. In 2001, Joint Commission on Accreditation of Healthcare Organizations replaced 
term conscious sedation with moderate sedation/analgesia; a drug-induced depression of 
consciousness during which patients respond purposefully to verbal commands, either 
alone or accompanied by light tactile stimulation and maintain adequate spontaneous 
ventilation and cardiovascular function. Reflex withdrawal from a painful stimulus is not 
considered a purposeful response. (2) Definitions of recently launched terminology 
“procedural sedation” vary widely.  
Procedural sedation and analgesia (PSA) is a more accurate and appropriate description. 
The term procedural sedation has emerged from the American College of Emergency 
Physician (ACEP) (3).    
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The concept behind PSA is to produce a state of sedation and analgesia with a minimal 
depression of consciousness where patient can tolerate unpleasant procedures but can 
maintain spontaneous respiration and airway-protective reflexes. Airway assistance ideally 
should not be required and the patient should be capable of responding to physical and 
verbal stimulus. PSA is also helpful for managing uncooperative patients in almost all the 
allied disciplines of healthcare including dentistry. 
3. Who can perform PSA 
The person performing the procedure should have sound understanding of medications 
used and able to monitor response and intervene to manage all potential complications. 
Expertise in airway management is mandatory, and the provider must be able to identify 
signs of airway complications both early and late in the course of procedure. Provider 
should be capable of maintaining airway during spontaneous ventilation and intermittent 
positive pressure ventilation with a mask and self-inflating resuscitation bag. 
PSA is a core competency in emergency medicine residency training and existing evidence 
supports the PSA administration by ED physician is as safe as by anesthesiologist. Hence, 
graduates of emergency medicine residency are qualified to for PSA in all age group. For 
other ED practitioner such as physician assistants, nurse practitioners and physician’s from 
other specialties such as family medicine working in ED; the chief of ED grants privileges 
for use of PSA.(3, 4) 
4. Patient selection 
Various patients requiring PSA in ED would be better served if the objectives of PSA are 
clear. Main objectives include patient safety, minimizing pain, anxiety and physical 
discomfort, negative psychological impact to treatment by providing analgesia and 
anxiolysis along with maximal potential for amnesia, patient movements during the 
procedure and maximizing the chances of success of procedure and returning the patient to 
pre-sedated state where safe discharge is possible.  
 
 
Physical Status Classification 
 
I: A normal healthy patient 
II: A patient with mild systemic disease 
III: A patient with severe systemic disease 
IV: A patient with severe systemic disease that is a constant threat to life 
V: A moribund patient who is not expected to survive without the operation 
VI: A declared brain-dead patient whose organs are being removed for donor 
purposes 
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Patients undergoing PSA should be assessed for physical status. It could be done using 
Physical Status Classification issued by American Society of Anesthesiologists. Procedural 
sedation is appropriate for patients in Classes I, II and III. Procedures for class IV and higher 
are done in operating room.  
There are no absolute contraindications, but things to consider are patients’ co-morbid 
illness or injuries, problems with prior PSA, the ability of provider and facilities to manage 
the patient’s airway. Patients with significant co-morbidity, minimal cardiopulmonary 
reserve and anticipated difficult airway should be cautiously approached.  Another relative 
contraindication is ingestion of large food or fluid volumes shortly before procedure, less 
than 2 hours, for risk of aspiration. Role of fasting in emergency PSA is not very clear and 
risk of aspiration should be weighted over risk from delay in procedure.(5)  
5. Preparation 
Preparation for PSA includes pre-sedation patient assessment, arranging equipments and 
choosing right pharmacological agent. Equipments necessary consists equipments to 
perform the procedure, monitoring and to manage potential complications. Performing 
time-out prior to the procedure is vital in performing right procedure in right patient.  The 
most common reported complication of moderate sedation is respiratory depression. In 
PSA, multiple studies have concluded that respiratory depression can be detected early 
measuring end-tidal CO2 when compared to oxygen saturation.  A change of 10% in end-
tidal CO2 and loss of wave pattern in capnography are indicators of respiratory depression. 
Use of supplemental oxygen has not been promoted much. American society of 
Anesthesiologists recommends using supplemental oxygen in deep sedation but does not 
have similar recommendation for moderate sedation. In many EDs, PSA is performed with 3 
litres of supplemental but other ED physician raise concern on use of supplemental oxygen 
concealing respiratory depression. Current evidence on routine use of supplemental oxygen 
to avoid hypoxia from respiratory depression is controversial. Low dose oxygen 
supplemental oxygen doesn’t decrease the risk of hypoxia but high dose does. Fortunately, 
hypoxemia induced by respiratory depression is either self-limiting or reversible with 
oxygen supplementation. Hence, routine use is not recommended. 
 
Equipments for PSA 
1. Intravenous access, peripheral is adequate 
2. Monitoring equipments; cardiac monitor, pulse oximetry, blood pressure 
cuff, capnography 
3. Pharmacological agent 
4. Reversal agents 
5. Equipments for procedure 
6. Airway equipments; oxygen supply, face mask/nasal cannula, bag-valve-
mask, suction 
7. Rescue airway equipments; endotracheal tube, direct laryngoscope, 
laryngeal mask airway 
8. Normal saline 
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6. Pharmacological agents 
A perfect agent for PSA should have rapid onset of action, short duration, rapid, smooth 
and complete recovery, devoid of adverse effects and able to produce adequate sedation, 
analgesia and amnesia. Till date, there is no perfect agent available which has all the above-
mentioned properties. 
7. Deep sedative agents 
7.1 Propofol  
Propofol is an ultrashort-acting sedative-hypnotic agent that produces dose-dependent, 
progressive suppression of awareness. Clinical sedation usually begins within 30 seconds 
from the time of injection and resolves within 6 minutes. Serum concentration drops from 
rapid distribution and metabolic clearance. It was first used in 1996 for PSA in ED and 
gained popularity after year 2000 because of its short duration of action, early and complete 
recovery and cost-effectiveness. Currently, it is most popular deep sedative being used in 
ED with over 90% satisfaction in both patients and physicians. (6) Based on current 
evidences, propofol is safe and efficacious in ED procedures requiring deeper level of 
sedation such as fracture and dislocation reduction, cardioversion, incision and drainage of 
abscess. It is not an optimal agent to induce minimal to moderate level of sedation. Another 
disadvantage is not having analgesic properties. Synergistic use of opiate analgesics is 
associated with higher respiratory depression and achieving near-complete analgesia using 
opiates prior to propofol infusion is advisable.  
Cautions: There are no absolute contraindications apart from allergy to propofol, egg or soy 
products. Propofol is known for dose dependent hypotension that is reversible with level of 
sedation. Hypotension is more pronounced in volume-depleted patients and should be 
replete prior to procedure. Advance age is found to have higher incidence of hypotension 
and respiratory depression. (7) This effect is most likely related with high serum peak 
concentration but exact pathophysiology is not yet clear. 
Monitoring: Overall, propofol is safe property but due to highly potent sedative agent and 
little alteration in serum concentration can make swings in level of consciousness and also 
produce cumulative sedation. Hence, sound understanding of pharmacological properties 
of propofol, abilities to monitor, intervene and resuscitate if needed for complications from 
deeper sedation are must for ED physician performing PSA. A dedicated nurse should be 
available during the procedure. At this point it is not very clear if another ED physician is 
needed to perform PSA in addition to physician performing procedure. 
Recovery: Patients should be monitored until they return to their baseline mental status. 
Once they reach to baseline mental status, it is unlikely to have suppression of 
consciousness from redistribution but caution is advised in cases with use of protocol for 
longer duration with multiple doses. Emesis during recovery is infrequent, in less than 3% 
and no adverse events is reported post-discharge. 
7.2 Etomidate  
Etomidate is an ultra-short acting non-barbiturate imidazole derivative, which is well 
known inducing agent for rapid sequence intubation in the ED. It produces deep sedation 
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similar to propofol. Onset of action is usually within one minute when administered 
intravenously and patient recovers from sedation with-in 6 to 16 minutes.  It has minimal, if 
any, analgesic property but gained popularity for minimal effect on hemodynamic stability. 
The liver metabolizes etomidate rapidly, and the duration of effect may be longer in patients 
with liver failure. Indication profile for etomidate is similar to propofol but gets priority 
when hemodynamic stability is matter of concern. Additionally, etomidate provides 
excellent amnesia of the procedure; over 70% of patients have no recall of procedure. 
 
Cautions: The only contraindication to etomidate is hypersensitivity to the medication, but 
caution should be taken during pregnancy (etomidate is a pregnancy category C drug), and 
the general precautions regarding procedural sedation and patient selection also should be 
considered. Side effects are usually rare, and there is no histamine release and hence 
minimal hemodynamic usability. Myoclonus is commonly reported side effect, up to 20% of 
cases, but not evident in rapid sequence intubation secondary to concomitant use of 
paralytic agent. In most cases, it is transient and does not cause respiratory distress and does 
not need intervention. The ED physician using etomidate should be competent in managing 
severe myoclonus which happens very rarely and in that scenario, opening airway is 
difficult. Use of benzodiazepines can decrease the probability of myoclonus. Another 
commonly reported side effect is emesis, up to 4% of cases, which is self-limiting. 
Adrenocortical suppression has been reported after the use of a single bolus of etomidate, 
but one time use of etomidate in otherwise healthy patient is believed to be inconsequential.  
Monitoring: Monitoring in use of etomidate is similar to any deep sedative, using pulse 
oximetry, capnography and hemodynamic monitoring. Respiratory depression and hypoxia 
are possible as part of deep sedation for which supplemental oxygen is enough but rarely 
might require bag-and-mask ventilation. 
Recovery and discharge: Recovery with use of etomidate is rapid and complete and once 
patient is back to baseline level of awareness, could be discharged and no adverse effect 
reported post discharge.  
Overall, both deep sedative agents provide similar level of sedation, respiratory suppression 
but propofol is devoid of myoclonus and emesis and have better success rate of procedure. 
8. Dissociative anesthetic agent 
8.1 Ketamine  
Ketamine is a dissociative agent that dissociates central nervous system from outside stimuli 
and produces a state of analgesia, amnesia and sedation but maintains spontaneous 
Etomidate Administration 
 
0.1mg/kg body weight IV as initial dose followed 
by half dose every 3-5 minutes titrating for clinical 
sedation. 
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respiration, protective airway reflexes and hemodynamic stability. Dissociation is produced 
at a dosing threshold below which patient has analgesia and disorientation and higher dose 
does not deepen the level of sedation.  It is commonly used in short painful and emotionally 
disturbing procedures such as laceration repair, incision and drainage, reduction of 
orthopedic fractures and dislocation in children and in mentally disabled patients who are 
often uncooperative. It is not very popular for procedures where motionless sedation is 
required as occasional random movements are common in dissociative sedation. 
 
Cautions: Ketamine is absolutely contraindicated in infants younger than 3-month for 
laryngospasm and apnea and in schizophrenia as it exacerbates the condition. To prevent 
the risk of laryngospasm – avoid vigorous stimulation of posterior pharyngeal wall, use in 
anatomical defect of airway such as stenosis or recent surgery etc, upper respiratory tract 
infection and in asthma. Ketamine decreases re-uptake of catecholamines, which leads to 
increased sympathomimetic activity.  For this reason ketamine should be avoided in 
children and adult with known or possible coronary artery disease, congestive heart 
failure and hypertension. Sympathomimetic action is exacerbated in patients with 
porphyria and thyroid disease, hence should be used with caution. Ketamine increases 
intracranial and intraocular pressure and should be avoided in hydrocephalus, 
intracranial masses/abnormalities, acute globe injury and glaucoma but no more 
contraindicated in head injury as cerebral vasodilatation caused by ketamine is potentially 
beneficial. 
Monitoring: Pulse oximetry, cardiac monitoring and capnography are recommended. 
Capnography is increasingly recommended for early detection of respiratory compromise. 
Co-administration of anti-cholinergic agents to decrease oral secretions, benzodiazepines to 
decrease recovery reaction, antiemetic agents for emesis that is common with intramuscular 
administration of ketamine is being practiced. Based on current evidences, prophylactic use 
of these agents is no superior than as needed basis use. Respiratory depression is 
uncommon with ketamine but can happen with IV dosing, 1-2 minutes after dose. 
Recovery and discharge: Ketamine is known for hallucinations, agitation and emesis during 
recovery. Recovery reactions are more common in late adolescents and can be rapidly taken 
care of with use of short acting benzodiazepines. Emesis could occur hours after the 
procedure. Ataxia has been reported post-discharge and close observation by family 
member is recommended. At this point, there are no standard guidelines for discharge. 
Once patient returns to pre-treatment level of awareness, vocalization and activity is 
achieved, could be discharged. 
Ketamine Administration 
 
IV route: 1.5mg/kg in children and 1mg/kg in 
adults as initial dose and repeat half doses for 
prolonged sedation 
IM route: used if no IV access, 4 to 5mg/kg as initial 
dose to induce sedation and repeated as half dose 
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8.2 Benzodiazepines and opioids 
Benzodiazepines act by binding to benzodiazepine-specific receptors on the gamma-
aminobutyric acid (GABA)-benzodiazepine receptor complex and potentiate GABA 
inhibitory action in the CNS and produce sedation, amnesia, anxiolysis, anticonvulsant 
effects and respiratory depression.  
Midazolam is the most commonly used benzodiazepines for PSA, as it has early onset of 
action producing more complete amnesia, less pain on injection and improved awakening 
when compared with diazepam. Midazolam possesses a relatively high volume of 
distribution (Vd) compared with other benzodiazepines because of its lipophilicity. The 
Vd is greatly amplified in obese patients, resulting in an increased half-life from 2.7 hours to 
8.4 hours. On usual dose, sedation is induced within 1-2 minutes and lasts up-to 30 minutes. 
Midazolam is frequently combined with a short acting opioid; this combination is titrated 
easily and widely available.   
 
Fentanyl is a favored opioid as it has prompt onset and short duration of action, and it also 
has minimal cardiovascular depressive effects and hypotension unlike morphine. Fentanyl 
binds with stereospecific receptors at many sites within the CNS and increases pain 
threshold, alters pain reception, and inhibits ascending pain pathways. In addition to 
analgesia, opioid agonists suppress the cough reflex and cause respiratory depression, 
drowsiness, and sedation. Onset of analgesia begins within 1-2 minutes and lasts up-to 30 to 
60 minutes. 
 
8.3 Barbiturates 
This group of drug is one of the oldest classes of drug and their role is mostly restricted to 
operating room and occasionally ICU, occasionally they may be used for providing sedation 
outside operating rooms setting. They have been traditionally classified on the basis of their 
duration of action. Methohexital, thiopental and thiamylal are short acting; pentobarbital is 
intermediate and phenobarbital fall under long acting group. Their have been few studies 
on their role in providing sedation to pediatric population in radiological suite during early 
and late 90s, however due to availability of better and safe alternative they are not the 
Fentanyl Administration 
1 to 1.5mcg/kg body weight IV in adults as initial 
dose followed by 1mcg/kg every three minutes for 
prolonged analgesia 
Midazolam Administration 
0.02 mg/kg body weight IV in adults and 0.1 mg/kg 
IV in children less than 5 years of age as initial dose 
followed by 1mg IV every 3 minutes during 
prolonged sedation 
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preferred drugs to provide sedation among anesthesiologists and emergency care physician 
anymore.  
8.4 Remifentanyl 
Remifentanyl is a recent addition in the list of pharmacological agents that has gained 
popularity amongst anesthetist and emergency physician, it’s a short acting μ-receptor 
opioid agonist and achieves peak analgesic effect in less than a minute and has an 
elimination half life of about ten minutes. Due to this short action of the drug, sustained 
analgesia may require an additional dose or an intravenous infusion. Different dose 
regimens are in use but the most often used ones were an intravenous bolus dose of 1 µg/kg 
over 1 minute. Alternatively it can also be titrated to individual needs with an infusion rates 
ranging from 0.025 - 0.1 µg/kg/min for conscious sedation (8). Recent studies have proved 
safety and efficacy of remifentanyl for PSA when used along with propofol (9 - 11).  
Caution: Combination of propofol and remifentanyl has good safety profile as compared to 
the combination of remifentanyl and midazolam and is being increasingly used due to its 
safety profile as compared to other agents.   
Monitoring: Standard monitoring of PSA is recommended, using pulse oximetry, 
capnography, and cardiac monitoring 
8.5 Dexmedetomidine  
Dexmedetomidine is a selective α-2 adrenoceptor agonist was approved by FDA in the year 
1999 for sedation in intensive care (13). It causes hyperpolarization of noradrenergic 
neurons, thereby suppressing the neuronal firing in locus ceruleus along with inhibition of 
norepinephrine release and activity in descending medullospinal nor-adrenergic pathways. 
This drug has recently being in focus due to its sedative, analgesic, perioperative 
sympatholytic properties. Along with all these properties, it is also hemodynamically stable 
with minimal effect on respiratory drive making it an ideal sedative agent and useful in 
various clinical scenarios. This drug has now become a safe alternative to 
benzodiazepine/opioid combination for monitored anesthesia care (14). The recommended 
dose range for dexmedetomidine is 0.2 – 0.7 µg / kg/hr. Although it preserves respiratory 
drive at higher doses it may lead to hypotension and bradycardia. 
8.6 Reversal of sedation 
Reversal of sedation is rarely required if pharmacological agents are carefully chosen based 
on nature of procedure. The commonly used agents are: 
Naloxone: It is administered to antagonize opioid induced respiratory depression and 
sedation. Naloxone is non-selective opiod antagonist and can precipitate sudden severe 
pain. It has a very fast onset of action with peak effect in 1-2 minutes and effect of total dose 
of 0.4 to 0.8 mg lasting for 1 to 4 hours. Incremental dose of 20 to 40 µg may be given every 
few minutes till the ventilation of the patient improves. Infusion rate between 3-10 µg/hr 
may be started if prolonged ventilatory depression is anticipated. 
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Flumazenil: It is a pure benzodiazepine antagonist which promptly reverses the hypnotic 
effect of benzodiazepine. This drug has chemical structure which is similar to 
benzodiazepine, except that it has carbonyl group in place of phenyl. It’s onset of action is 
less than one minute, and undergoes rapid hepatic metabolism with a half life of 1 hour. 
When it’s used to antagonize the action of benzodiazepine with long duration of action, 
there are chances of recurrence of the symptoms. The usual total dose is 0.6 to 1.0 mg given 
as a gradual titrated dose of 0.2 mg / minute until the desired level of reversal is achieved. It 
is given as IV infusion if over dosage with a long-acting benzodiazepine is suspected.  This 
review will not be complete without adding a note of caution that use of flumazenil may 
precipitate seizure activity that are being chronically treated with benzodiazepine or in 
those group of patients who are being treated with drugs that reduces seizure threshold like 
tricyclic antidepressants. 
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